Higher Adherence to Treatment with Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin because of Side Effects in Cancer-Associated Venous Thromboembolism

  1. Van Der Wall, S.J.
  2. Klok, F.A.
  3. Den Exter, P.L.
  4. Barrios, D.
  5. Morillo, R.
  6. Cannegieter, S.C.
  7. Jimenez, D.
  8. Huisman, M.V.
Revista:
HemaSphere

ISSN: 2572-9241

Any de publicació: 2018

Volum: 2

Número: 1

Tipus: Article

DOI: 10.1097/HS9.0000000000000019 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus